Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 North America Human Insulin Market, by Indication
1.4.2 North America Human Insulin Market, by Product Type
1.4.3 North America Human Insulin Market, by Type of Insulin
1.4.4 North America Human Insulin Market, by Distribution Channel
1.4.5 North America Human Insulin Market, by Country
1.5 Methodology for the research
Chapter 2. Market at a Glance
2.1 Key Highlights
Chapter 3. Market Overview
3.1 Introduction
3.1.1 Overview
3.1.1.1 Market Composition and Scenario
3.2 Key Factors Impacting the Market
3.2.1 Market Drivers
3.2.2 Market Restraints
3.2.3 Market Opportunities
3.2.4 Market Challenges
3.3 Porter Five Forces Analysis
Chapter 4. North America Human Insulin Market by Indication
4.1 North America Type 1 Diabetes Market by Country
4.2 North America Type 2 Diabetes Market by Country
4.3 North America Gestational Diabetes Market by Country
Chapter 5. North America Human Insulin Market by Product Type
5.1 North America Pens Market by Country
5.2 North America Syringes Market by Country
5.3 North America Others Market by Country
Chapter 6. North America Human Insulin Market by Type of Insulin
6.1 North America Rapid-acting insulin Market by Country
6.2 North America Short-acting insulin Market by Country
6.3 North America Intermediate-acting insulin Market by Country
6.4 North America Others Market by Country
Chapter 7. North America Human Insulin Market by Distribution Channel
7.1 North America Hospital Pharmacies Market by Country
7.2 North America Drug Stores & Retail Pharmacies Market by Country
7.3 North America Online Providers Market by Country
Chapter 8. North America Human Insulin Market by Country
8.1 US Human Insulin Market
8.1.1 US Human Insulin Market by Indication
8.1.2 US Human Insulin Market by Product Type
8.1.3 US Human Insulin Market by Type of Insulin
8.1.4 US Human Insulin Market by Distribution Channel
8.2 Canada Human Insulin Market
8.2.1 Canada Human Insulin Market by Indication
8.2.2 Canada Human Insulin Market by Product Type
8.2.3 Canada Human Insulin Market by Type of Insulin
8.2.4 Canada Human Insulin Market by Distribution Channel
8.3 Mexico Human Insulin Market
8.3.1 Mexico Human Insulin Market by Indication
8.3.2 Mexico Human Insulin Market by Product Type
8.3.3 Mexico Human Insulin Market by Type of Insulin
8.3.4 Mexico Human Insulin Market by Distribution Channel
8.4 Rest of North America Human Insulin Market
8.4.1 Rest of North America Human Insulin Market by Indication
8.4.2 Rest of North America Human Insulin Market by Product Type
8.4.3 Rest of North America Human Insulin Market by Type of Insulin
8.4.4 Rest of North America Human Insulin Market by Distribution Channel
Chapter 9. Company Profiles
9.1 Biocon Limited
9.1.1 Company Overview
9.1.2 Financial Analysis
9.1.3 Research & Development Expenses
9.2 Tonghua Dongbao Pharmaceutical Co., Ltd.
9.2.1 Company Overview
9.3 Lupin Limited
9.3.1 Company Overview
9.3.2 Financial Analysis
9.3.3 Regional Analysis
9.3.4 Research & Development Expenses
9.3.5 SWOT Analysis
9.4 MannKind Corporation
9.4.1 Company Overview
9.4.2 Financial Analysis
9.5 Sanofi S.A.
9.5.1 Company Overview
9.5.2 Financial Analysis
9.5.3 Segmental and Regional Analysis
9.5.4 Research & Development Expense
9.5.5 SWOT Analysis
9.6 Novo Nordisk A/S
9.6.1 Company Overview
9.6.2 Financial Analysis
9.6.3 Segmental & Regional Analysis
9.6.4 Research & Development Expenses
9.6.5 SWOT Analysis
9.7 Medtronic PLC
9.7.1 Company overview
9.7.2 Financial Analysis
9.7.3 Segmental and Regional Analysis
9.7.4 Research & Development Expenses
9.7.5 SWOT Analysis
9.8 Eli Lilly And Company
9.8.1 Company Overview
9.8.2 Financial Analysis
9.8.3 Regional Analysis
9.8.4 Research & Development Expenses
9.8.5 SWOT Analysis
9.9 Pfizer, Inc.
9.9.1 Company Overview
9.9.2 Financial Analysis
9.9.3 Regional & Segmental Analysis
9.9.4 Research & Development Expense
9.9.5 SWOT Analysis
Unique Offerings 